15489090

Source:http://linkedlifedata.com/resource/pubmed/id/15489090

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004083, umls-concept:C0013216, umls-concept:C0018801, umls-concept:C0030705, umls-concept:C1274040, umls-concept:C1565489, umls-concept:C1956346
pubmed:issue	8
pubmed:dateCreated	2004-10-18
pubmed:abstractText	This study was designed to examine the use of cardiovascular medications and outcomes in patients with heart failure (HF) and renal dysfunction.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15489090-15936627
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Cardiovascular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0735-1097
pubmed:author	pubmed-author:APPROACH Investigators, pubmed-author:EzekowitzJustinJ, pubmed-author:GhaliWilliam AWA, pubmed-author:HumphriesKarin HKH, pubmed-author:KnudtsonMerril LML, pubmed-author:McAlisterFinlay AFA, pubmed-author:NorrisColleen MCM, pubmed-author:TonelliMarcelloM
pubmed:issnType	Print
pubmed:day	19
pubmed:volume	44
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1587-92
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15489090-Adrenergic beta-Antagonists, pubmed-meshheading:15489090-Aged, pubmed-meshheading:15489090-Aged, 80 and over, pubmed-meshheading:15489090-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15489090-Aspirin, pubmed-meshheading:15489090-Cardiovascular Agents, pubmed-meshheading:15489090-Cause of Death, pubmed-meshheading:15489090-Cohort Studies, pubmed-meshheading:15489090-Comorbidity, pubmed-meshheading:15489090-Coronary Artery Disease, pubmed-meshheading:15489090-Creatinine, pubmed-meshheading:15489090-Drug Utilization, pubmed-meshheading:15489090-Female, pubmed-meshheading:15489090-Heart Failure, pubmed-meshheading:15489090-Humans, pubmed-meshheading:15489090-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15489090-Kidney Failure, Chronic, pubmed-meshheading:15489090-Likelihood Functions, pubmed-meshheading:15489090-Male, pubmed-meshheading:15489090-Medical Futility, pubmed-meshheading:15489090-Middle Aged, pubmed-meshheading:15489090-Odds Ratio, pubmed-meshheading:15489090-Survival Analysis, pubmed-meshheading:15489090-Ventricular Dysfunction, Left
pubmed:year	2004
pubmed:articleTitle	The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
pubmed:affiliation	Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada T6G 2R7.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't